- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1876-6250
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Biomarkers in heart failure with preserved ejection fraction ; day:4 ; month:3 ; year:2016 ; pages:1-7
Netherlands heart journal ; (4.3.2016), 1-7
- Urheber
-
Meijers, W. C.
- Beteiligte Personen und Organisationen
-
Velde, A. R. van der
Boer, R. A. de
SpringerLink (Online service)
- DOI
-
10.1007/s12471-016-0817-7
- URN
-
urn:nbn:de:1111-201603084198
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Meijers, W. C.
- Velde, A. R. van der
- Boer, R. A. de
- SpringerLink (Online service)
Ähnliche Objekte (12)
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Understanding heart failure with preserved ejection fraction: where are we today?
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Understanding heart failure with preserved ejection fraction: where are we today?
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction